Alere acquires Arriva Medical for $65 million, plus stock

12/2/2011 | Clinica (subscription required)

Arriva Medical, which supplies blood glucose monitors and other diabetes testing devices to patients' homes, has been acquired by in vitro diagnostics firm Alere for $65 million in cash, plus 806,452 restricted company shares. The deal will allow Alere to expand its footprint in the point-of-care diabetes diagnostics arena.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX